CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-08 | Anand Bhaskar Chief Accounting Officer | Grant or award | +100,000 | 261,047 | ||
| 2026-01-08 | Anand Bhaskar Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-10-21 | Anand Bhaskar Chief Accounting Officer | Grant or award | +26,680 | $18.74 | $500K | 159,751 |
| 2025-09-18 | Anand Bhaskar Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-04-29 | Anand Bhaskar Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-04-29 | Anand Bhaskar Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-01-12 | Anand Bhaskar Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2024-09-11 | Anand Bhaskar Chief Accounting Officer | Grant or award | +22,026 | $22.70 | $500K | 131,426 |
| 2024-04-02 | Anand Bhaskar Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 |
Page 1 of 1 · 9 trades